Two RespiraSense™ Clinical Research Posters, on the efficacy of respiratory rate monitoring, developed in collaboration with our centre of excellence will be on show in Belfast on Thursday, 24th and Friday, 25th January as part of the BOMMS Scientific Meeting.
PMD Solutions, an industry-leading medical technology company based in Cork, Ireland, today announced the issuance of Japanese Patent No. 6401718 Titled “A Method and Device for Respiratory Monitoring” issued September 14, 2018.
UCLPartners is supporting four trusts to take part in the set-up phase for a pilot of PMD Solutions’ RespiraSense™, the world’s only continuous and motion-tolerant respiratory rate monitor.
Frost & Sullivan awards PMD Solutions with the 2018 Visionary Innovation Leadership award for the non-invasive respiratory market at the Best Practices banquet in London. Best practice companies lead the way and set the example for others. The Best Practices Awards have identified exemplary achievements within a multitude of industries and functional disciplines for the last 18 years. Frost & Sullivan conducts best practices research to properly identify unrivalled innovation and leadership among companies, products, processes and executives.
Leading provider of respiratory monitoring technology, PMD Solutions saw outstanding success at this year’s MEDICA event. Showcasing its revolutionary RespiraSense™ product, the high growth early stage medical device company was invited by Enterprise Ireland to be part of the Irish pavilion where they were represented on a world stage among some of the globes leading Medtec organisations.
PMD Solutions, an industry-leading medical technology company based in Cork Ireland, today announced its successful enrolment in the NHS Innovation Accelerator (NIA) Programme as part of the NIA’s official kick-off launch event which took place in London this week.
SBRI Healthcare, the small Business Research Initiative for Healthcare (SBRI Healthcare), is an NHS England Initiative, led by the country’s 15 Academic Health Science Networks (AHSNs). Its role is to promote UK economic growth by spreading innovation and best practice across the NHS. Winners receive fully funded development contracts between the awarded company and NHS England to meet known healthcare needs.
Myles Murray (CEO – PMD Solutions) excites dotMED to become outright winner with his vision of the use of technology for positive impacts in the future of Irish Healthcare.
PMD Solutions is one of 38 innovative SMEs across Europe selected from the latest round of Horizon 2020 SME Instrument (Phase 2). The funding will be used to finance innovation activities like demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. The companies will also benefit from 12 days of business coaching.
PMD Solutions has received regulatory approvals for the sales and marketing of the RespiraSense Continuous Respiratory Monitoring device across the European Union.
This milestone now enables PMD Solutions to establish a wider presence by leveraging European approvals in countries on other continents.